Stay updated on Arimoclomol Early Access Program in US Patients With NPC Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol Early Access Program in US Patients With NPC Clinical Trial page.

Latest updates to the Arimoclomol Early Access Program in US Patients With NPC Clinical Trial page
- Check6 days agoChange DetectedThe page revision in the footer updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision (v3.4.2) was added to the history, and an older funding notice and revision entry (v3.4.1) were removed.SummaryDifference0.6%

- Check41 days agoChange DetectedAdministrative updates: the history page shows a new funding/operating-status notice and changes the revision tag to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check48 days agoChange DetectedAdded a glossary toggle and color-coded indicators for additions (green) and deletions (red); updated revision to v3.4.0 and removed older FEAR Act data notes (v3.3.4).SummaryDifference0.8%

- Check62 days agoChange DetectedA new revision entry labeled v3.3.4 was added to the Record History. The previous revision entry v3.3.3 is removed from the current list.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.3.3 was added to the page history and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed from the footer.SummaryDifference0.2%

Stay in the know with updates to Arimoclomol Early Access Program in US Patients With NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol Early Access Program in US Patients With NPC Clinical Trial page.